Literature DB >> 11540295

Endocrine, renal, and circulatory influences on fluid and electrolyte homeostasis during weightlessness: a joint Russian-U.S. project.

A I Grigoriev1, C L Huntoon, B V Morukov, H W Lane, I M Larina, S M Smith.   

Abstract

Microgravity is known to have a substantial effect on fluid homeostasis. The research described here was planned as part of the first joint Russian-U.S. science program carried out during a Shuttle flight. The aim of the program was to study the nature of the changes in fluid homeostasis induced by microgravity, as well as to determine the possible mechanisms underlying the regulation of fluid balance under conditions of spaceflight. To determine the effects of spaceflight on the homeostasis of fluid and electrolytes, measurements were taken of total body water, extracellular fluid plasma volumes, levels of regulatory hormones, and nutrient consumption before, during, and after a nine-day flight. Changes in renal function were studied before and after the flight. In these 2 subjects, weightlessness was not associated with a decreased extracellular fluid volume. However, there were the characteristic decreases in plasma atrial natriuretic peptide concentrations, and increases in plasma and urinary cortisol. Results indicated decreased urine volume, even through the first 48 hours of flight. Fluid volumes and glomerular filtration rate were increased after landing, probably related to the saline-loading countermeasure used by Shuttle crewmembers. The information obtained as a result of this research will facilitate the development of future research programs, as well as preventive measures for future long-duration spaceflights.

Entities:  

Keywords:  NASA Center JSC; NASA Discipline Regulatory Physiology

Mesh:

Substances:

Year:  1996        PMID: 11540295

Source DB:  PubMed          Journal:  J Gravit Physiol        ISSN: 1077-9248


  1 in total

Review 1.  Medications in Space: In Search of a Pharmacologist's Guide to the Galaxy.

Authors:  Sara Eyal; Hartmut Derendorf
Journal:  Pharm Res       Date:  2019-08-14       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.